StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Solventum (SOLV) PT Raised to $102 at KeyBanc
August 6, 2026 5:32 AM
KeyBanc analyst Brett Fishbin raised the price target on Solventum (NYSE:
SOLV
) to $102.00 (from $93.00) while maintaining a Overweight rating.
Categories
Analyst PT Change